胰岛素抵抗
生物利用度
串扰
平衡
葡萄糖稳态
化学
药理学
2型糖尿病
医学
内科学
内分泌学
胰岛素
糖尿病
2型糖尿病
作者
Wenji Zhang,Wenli Cheng,Jiaqi Fu,Ruidong Zeng,Zhangying Wang,Jingbo Zhou,Yibo Chen,Wenjuan Zhang
标识
DOI:10.1016/j.jare.2025.12.025
摘要
INTRODUCTION: Integrated multi-omics analysis has revolutionized the investigation of plant-derived compounds for type 2 diabetes mellitus (T2DM). Solanesol, a bioactive constituent from Solanaceae plants, exhibits high oral bioavailability and translational potential for multi-target therapeutics. OBJECTIVES: This study aimed to elucidate the multi-target mechanisms and multi-organ protective effects of solanesol in T2DM management through integrated multi-omics approaches, to bridge the gap between phytochemical discovery and clinical translation. METHODS: murine models (8-13 weeks), solanesol (1-15 mg/kg/day, i.g.) was compared with metformin (200 mg/kg/day). Serum biochemical parameters were quantified using ELISA/colorimetric assays. Quantitative pathology analysis was performed on H&E/PAS/Masson-stained sections for assessment of hepatic steatosis and glycogenesis. Mitochondrial respiratory chain complexes (I-V) expression and activities were validated by qRT-PCR and ELISA assay, respectively. Multi-omics profiling included gut microbiota sequencing (16S rRNA), fecal metabolomics/lipidomics (UHPLC-Q LC-MS/MS), and hepatic transcriptome/proteome analysis (RNA-seq, 4-Dimensional Label-Free Quantification (4D-LFQ)). Long-/medium-/short-chain fatty acids were detected by GC-MS. RESULTS: Solanesol improved glucose tolerance, insulin sensitivity, and reduced serum lipids, hepatic gluconeogenesis, uric acid, white adipose mass, pancreatic/hepatic inflammation, and renal fibrosis. Mechanistically, solanesol: 1) enriched beneficial gut microbiota (Alistipes, Anaerotruncus, and Parasutterella) and increased levels of long-chain unsaturated fatty acids; 2) rebalanced the dysfunctional mitochondrial oxidative phosphorylation microenvironment by modulating the expression and the activities of respiratory chain Complexes I-V; 3) modulated hepatic lipid metabolism by inhibiting de novo lipogenesis via the Acly-Acaca-Fasn pathway, promoting cholesterol efflux and fatty acid oxidation through Abca1/Fabp5, and attenuating inflammation via Lpl-PPARδ downregulation. CONCLUSION: Solanesol demonstrates multi-organ protective effects through gut microbiota-metabolite crosstalk and hepatic lipid/redox homeostasis regulation. Its multi-target efficacy and oral bioavailability position it as a novel, clinically translatable candidate for T2DM management.
科研通智能强力驱动
Strongly Powered by AbleSci AI